Global Burden of Skin Disease as Reflected in<i>Cochrane Database of Systematic Reviews</i>

Karimkhani, Chanté; Boyers, Lindsay N.; Prescott, Laura; Welch, Vivian; Delamere, Finola M; Nasser, Mona; Zaveri, Amrapali; Hay, Roderick J.; Vos, Theo; Murray, Christopher J L; Margolis, David J.; Hilton, John; MacLehose, Harriet; Williams, Hywel C; Dellavalle, Robert P.

doi:10.1001/jamadermatol.2014.709

Cited by 75 publications

(63 citation statements)

References 22 publications

(19 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[1][2][3][4] GBD facilitates epidemiologic comparison of disease burden. 5,6 Fifteen skin conditions are represented in the study along with a category for ''other skin and subcutaneous diseases.'' Before GBD 2010, in 1998, the Institute of Medicine (IOM) urged the National Institutes of Health (NIH) to correlate burden of disease with US funding distribution.…”

mentioning

confidence: 99%

Comparing cutaneous research funded by the US National Institutes of Health (NIH) with the US skin disease burden

Hagstrom

Patel

Karimkhani

et al. 2015

Journal of the American Academy of Dermatology

Self Cite

View full text Add to dashboard Cite

show abstract

mentioning

confidence: 99%

Comparing cutaneous research funded by the US National Institutes of Health (NIH) with the US skin disease burden

Hagstrom

Patel

Karimkhani

et al. 2015

Journal of the American Academy of Dermatology

Self Cite

View full text Add to dashboard Cite

show abstract

“…Las enfermedades dermatológicas más prevalentes son las enfermedades inflamatorias cróni-cas. La psoriasis, los eccemas, el acné y el eccema de manos tienen una prevalencia combinada de, aproximadamente, el 25 % en los países desarrollados, seguidos por el cáncer de piel distinto al melanoma 5 .…”

Section: Impacto Psicológico Del Cáncer De Piel En La Vejezunclassified

Repercusión emocional del cáncer de piel y el envejecimiento cutáneo

Valladolid¹

2017

Más Dermatol

View full text Add to dashboard Cite

“…Measurement of skin disease burden using disability-adjusted life-year metrics allows comparison with other diseases. 768 Disease burden is an important but not exclusive component for guiding research funding. Further annual updates and refinements of the models used to asses global burden of disease are ongoing and serve as an important resource for prioritising future skin disease research.…”

Section: Impact Of This Research and Disseminationmentioning

confidence: 99%

A programme of research to set priorities and reduce uncertainties for the prevention and treatment of skin disease

Kim

Batchelor

Bath‐Hextall

et al. 2016

Programme Grants Appl Res

View full text Add to dashboard Cite

Programme Grants for Applied ResearchISSN 2050-4322 (Print) ISSN 2050-4330 (Online) This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE) (www.publicationethics.org/).Editorial contact: nihredit@southampton.ac.ukThe full PGfAR archive is freely available to view online at www.journalslibrary.nihr.ac.uk/pgfar. Print-on-demand copies can be purchased from the report pages of the NIHR Journals Library website: www.journalslibrary.nihr.ac.uk Criteria for inclusion in the Programme Grants for Applied Research journalReports are published in Programme Grants for Applied Research (PGfAR) if (1) they have resulted from work for the PGfAR programme, and (2) they are of a sufficiently high scientific quality as assessed by the reviewers and editors. Programme Grants for Applied Research programmeThe Programme Grants for Applied Research (PGfAR) programme, part of the National Institute for Health Research (NIHR), was set up in 2006 to produce independent research findings that will have practical application for the benefit of patients and the NHS in the relatively near future. The Programme is managed by the NIHR Central Commissioning Facility (CCF) with strategic input from the Programme Director.The programme is a national response mode funding scheme that aims to provide evidence to improve health outcomes in England through promotion of health, prevention of ill health, and optimal disease management (including safety and quality), with particular emphasis on conditions causing significant disease burden.For more information about the PGfAR programme please visit the website: http://www.nihr.ac.uk/funding/programme-grants-forapplied-research.htm This reportThe research reported in this issue of the journal was funded by PGfAR as project number RP-PG-0407-10177. The contractual start date was in September 2008. The final report began editorial review in April 2014 and was accepted for publication in April 2016. As the funder, the PGfAR programme agreed the research questions and study designs in advance with the investigators. The authors have been wholly responsible for all data collection, analysis and interpretation, and for writing up their work. The PGfAR editors and production house have tried to ensure the accuracy of the authors' report and would like to thank the reviewers for their constructive comments on the final report document. However, they do not accept liability for damages or losses arising from material published in this report.This report presents independent research funded by the National Institute for Health Research (NIHR). The views and opinions expressed by authors in this publication are those of the authors and do not necessarily reflect those of the NHS, the NIHR, CCF, NETSCC, PGfAR or the Department of Health. If there are verbatim quotations included in this publication the views and opinions expressed by the interviewees are those of the interviewees and do not necessarily reflect those of the authors, those of the NHS, the NIHR, ...

show abstract

Global Burden of Skin Disease as Reflected inCochrane Database of Systematic Reviews

Cited by 75 publications

References 22 publications

Comparing cutaneous research funded by the US National Institutes of Health (NIH) with the US skin disease burden

Comparing cutaneous research funded by the US National Institutes of Health (NIH) with the US skin disease burden

Repercusión emocional del cáncer de piel y el envejecimiento cutáneo

A programme of research to set priorities and reduce uncertainties for the prevention and treatment of skin disease

Contact Info

Product

Resources

About